Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

CACCIAPAGLIA, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.151
SA - Sud America 1.067
NA - Nord America 474
AF - Africa 145
EU - Europa 124
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.965
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 830
VN - Vietnam 527
US - Stati Uniti d'America 435
SG - Singapore 330
CN - Cina 126
AR - Argentina 98
MA - Marocco 98
EC - Ecuador 49
ID - Indonesia 45
CO - Colombia 28
HK - Hong Kong 27
BD - Bangladesh 26
IT - Italia 26
RU - Federazione Russa 24
PY - Paraguay 21
ZA - Sudafrica 20
MX - Messico 19
UA - Ucraina 16
CL - Cile 11
PE - Perù 10
UY - Uruguay 10
DE - Germania 9
IQ - Iraq 9
EG - Egitto 8
VE - Venezuela 8
AT - Austria 7
NL - Olanda 7
SY - Repubblica araba siriana 7
GB - Regno Unito 6
IN - India 6
PK - Pakistan 6
AZ - Azerbaigian 5
GT - Guatemala 5
NP - Nepal 5
UZ - Uzbekistan 5
CA - Canada 4
DO - Repubblica Dominicana 4
KZ - Kazakistan 4
SE - Svezia 4
TN - Tunisia 4
CG - Congo 3
KE - Kenya 3
KG - Kirghizistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
ES - Italia 2
FI - Finlandia 2
FR - Francia 2
HN - Honduras 2
IE - Irlanda 2
IR - Iran 2
JO - Giordania 2
JP - Giappone 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
AL - Albania 1
AU - Australia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
IM - Isola di Man 1
KW - Kuwait 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PL - Polonia 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TR - Turchia 1
Totale 2.965
Salva come PNG Salva come JPEG
Città #
Dallas 285
Ho Chi Minh City 191
Singapore 123
Hanoi 105
Hefei 104
Casablanca 92
São Paulo 64
The Dalles 31
Rio de Janeiro 28
Hong Kong 27
Da Nang 26
Boydton 21
Hải Dương 18
Guayaquil 17
Haiphong 17
Ashburn 16
Curitiba 16
Biên Hòa 14
Quito 14
Ribeirão Preto 13
Thái Bình 13
Teresina 11
Brasília 10
Porto Alegre 10
Can Tho 9
Fortaleza 9
Lấp Vò 9
Rio Bonito 9
Sorocaba 9
Montevideo 8
Phủ Lý 8
Salvador 8
Viamão 8
Atibaia 7
Belo Horizonte 7
Campinas 7
Goiânia 7
Ninh Bình 7
Pelotas 7
Asunción 6
Avellaneda 6
Bari 6
Bogotá 6
Bắc Ninh 6
Feira de Santana 6
Guarulhos 6
Johannesburg 6
Manaus 6
Naucalpan 6
Quảng Ngãi 6
Rome 6
Thái Nguyên 6
Buenos Aires 5
Bắc Giang 5
Cape Town 5
Jakarta 5
Lima 5
Ourinhos 5
Pindamonhangaba 5
Santiago de Cali 5
Santo André 5
St Petersburg 5
Vĩnh Tường 5
Bauru 4
Brooklyn 4
Cairo 4
Caracas 4
Catania 4
Concepción 4
Cuenca 4
Dhaka 4
Gravatá do Ibiapina 4
Ha Long 4
Hortolândia 4
Itaquaquecetuba 4
João Pessoa 4
Kathmandu 4
Los Angeles 4
Natal 4
Nova Iguaçu 4
Petrolina 4
Quảng Ninh 4
Seattle 4
São Gonçalo 4
Taboão da Serra 4
Varginha 4
Aracaju 3
Araxá 3
Baghdad 3
Baku 3
Bishkek 3
Bình Dương 3
Cametá 3
Campo Bom 3
Campos dos Goytacazes 3
Canoas 3
Charlotte 3
Curvelo 3
Florianópolis 3
Formiga 3
Totale 1.652
Salva come PNG Salva come JPEG
Nome #
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 50
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis 47
Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 47
Adherence to the 2019 ESC/EAS guidelines for dyslipidaemia management in a large rheumatoid arthritis cohort: Data from the CORDIS Study Group of the Italian Society of Rheumatology 47
APOPTOSIS AND AUTOIMMUNITY INDUCED BY CLODRONATE IN SYSTEMIC LUPUS ERYTHEMATOSUS MONONUCLEAR CIRCULATING CELLS 46
Atherosclerosis and Autoimmunity 41
Complete Hydatidiform Mole Mimicking Sacroiliitis 40
Apoptotic molecular mechanisms implicated in autoimmune diseases 40
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort 39
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis 39
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis 38
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues 38
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 38
Antinuclear antibodies prevalence in Filipinos migrated to Italy 37
Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels 37
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 37
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. 37
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis 37
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. 36
Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported 36
Influence of TNF-alpha inhibition on oxidative stress of rheumatoid arthritis patients 35
Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients 34
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents 34
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 34
The natural history of insulin content in the pancreas of female and mate non-obese diabetic mouse: implications for trials of diabetes prevention in humans 34
Traditional and non traditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study) 33
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 33
Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study 33
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 33
Inflammation and iron metabolism in adult patients with epilepsy: Does a link exist? 33
Effectiveness of tapering rituximab dose in idiopathic inflammatory myopathies: Real-world data from a monocentric study 32
Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors 32
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 32
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 31
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 31
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies 31
Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model 31
Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus. 30
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al 30
Janus kinase inhibitors: between prescription authorization and reimbursability 30
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome 30
Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis 30
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry 30
Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis 30
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 30
Possible role of adipocytokines in systemic sclerosis-associated small pericardial effusion 30
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre 29
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 29
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 28
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients. 28
Tumour necrosis factor alpha (TNFα) cardiomyocyte preconditioning: Clues to explain anti-TNFα agents contraindication in severe heart failure 28
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort 28
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement 28
Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus 28
Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey 28
Effectiveness of biological targeted therapies may discriminate seronegative from seropositive rheumatoid arthritis 28
The use of a glucose spray device to control progression towards hypoglycaemia 28
Italian recommendations for the assessment of cardiovascular risk in rheumatoid arthritis: a position paper of the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group of the Italian Society for Rheumatology 28
Sex Differences in Cardiovascular Risk Profiles of Patients with Rheumatoid Arthritis: Results from an Italian Multicentre Cohort 28
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 28
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 27
Disease activity assessment for juvenile idiopathic arthritis in transitional care 27
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors 27
Psoriatic arthritis and obesity: the role of anti-IL-12/IL-23 treatment 27
Matters of the Heart: The Case of TNF alpha-Targeting Drugs 27
Survival and Prognostic factors from a multicentre large cohort of unselected Italian Systemic Sclerosis patients 27
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of the scleroderma spectrum. 26
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 26
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group 26
Towards a comprehensive approach to the management and prognosis of systemic sclerosis's patients: The role of comorbidities in the SPRING-SIR registry 26
The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implication for trials of diabetes prevention in humans 26
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 26
Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment 26
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 26
Predictors of long-term clinical remission in rheumatoid arthritis 26
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus 25
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 25
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 25
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al. 25
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 25
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry. 25
Subcutaneous immunoglobulin therapy for refractory skin thickening in rapidly progressive systemic sclerosis: A case report and literature review 24
Lack of effect of vitamin D administration during pregnancy and early life on diabetes incidence in the non-obese diabetic mouse 24
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies 24
The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment 24
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 24
Pulmonary arterial hypertension: guidelines and unmet clinical needs. 24
Serum sCD40L levels are increased in patients with psoriatic arthritis and are associated with clinical response to apremilast. 23
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis 23
Low Level Tumor Necrosis Factor-Alpha Protects Cardiomyocytes Against High Level Tumor Necrosis Factor-Alpha: Brief Insight into a Beneficial Paradox 23
Safety profile and low risk of disease relapse after BNT162b2 mRNA SARS-COV-2 vaccination in patients with rare rheumatic diseases 23
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus 23
IL TUTORATO D'AULA 22
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA. 22
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 21
Varicella-zoster virus infection in rheumatoid arthritis patients in the anti-tumour necrosis factor era 21
Phosphorylated signal transducer and activator of transcription 3 (pSTAT3) is highly expressed in CD14+ circulating cells of scleroderma patients 21
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 21
New technologies aiding dietary programmes for weight control: the oral glucose spray 21
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection 20
Totale 3.001
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025462 0 0 0 120 24 97 28 17 46 24 77 29
2025/20262.607 47 312 775 1.368 73 32 0 0 0 0 0 0
Totale 3.069